Charles River Laboratories International (CRL) Revenue (2009 - 2025)

Charles River Laboratories International's Revenue history runs 17 years deep, the most recent figure standing at $994.2 million for Q4 2025.

• In Q4 2025, Revenue fell 0.83% year-over-year to $994.2 million; the TTM figure through Dec 2025 stood at $4.0 billion (down 0.85% YoY), while the FY2025 annual figure was $4.0 billion, down 0.85% from the prior year.
• Revenue for Q4 2025 stood at $994.2 million, down from $1.0 billion in the prior quarter.
• The five-year high for Revenue was $1.1 billion in Q4 2022, with the low at $824.6 million in Q1 2021.
• The 5-year median for Revenue is $1.0 billion (2024), against an average of $985.6 million.
• The sharpest annual moves came in 2021 and 2023: Revenue jumped 33.99% in 2021, then dropped 7.85% in 2023.
• Charles River Laboratories International's Revenue stood at $905.0 million in 2021, then rose by 21.52% to $1.1 billion in 2022, then declined by 7.85% to $1.0 billion in 2023, then slipped by 1.08% to $1.0 billion in 2024, then slipped by 0.83% to $994.2 million in 2025.
• Business Quant data shows CRL's Revenue at $994.2 million in Q4 2025, $1.0 billion in Q3 2025, and $1.0 billion in Q2 2025.